Zhejiang Jiaoke: the amount of newly signed orders in the first quarter was 9.488 billion yuan, and the order stock was sufficient

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Global Expansion Fuels BYD's Profit Recovery Above RMB 10 Billion

Overseas growth is powering BYD’s profit recovery, but rising trade barriers and the cash demands of global expansion are testing its momentum.

Hesai Reports ET-Series Lidar Design Wins with Five Automakers

Hesai Group（禾赛科技）said on November 10 that its ET-series main lidar had secured design wins with five automakers, including Cadillac（凯迪拉克）and a leading European carmaker. The company described the combined order book for the programs as exceeding 1 million units.

Li Auto Signs Partners in Five Asia-Pacific Markets, Plans Right-Hand-Drive MEGA Debut

Li Auto（理想汽车）announced on November 10 that it had signed cooperation agreements with partners in Thailand, Hong Kong, Singapore, the Philippines and Vietnam, expanding its sales network across the Asia-Pacific region.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?